Why Is Canada-Based Cannabis Firm Canopy Growth Stock Trading Lower On Friday?
On Friday, Canopy Growth Corporation (NASDAQ:CGC) reported third-quarter 2025 sales of CA$74.76 million, down from CA$78.51 million a year ago, beating the consensus of CA$69.11 million.
Excluding net revenue from businesses divested during the prior fiscal year, net revenue increased 8%, driven primarily by growth in Canada’s medical, international markets and Storz & Bickel.
Cannabis net revenue was CA$41 million, up 1%. Medical cannabis net revenue increased 16% compared, driven primarily by an increase in the average size of medical orders placed by customers.
Also Read: Why Aurora …